Description
ProcaterolisanagoNISTatβ2-adrenergicreceptorsthatexhibitsanti-inflammatory,anti-asthma,andbronchodilatoryactivities.Procaterolisusedtotreatasthma.Inanimalmodels,procaterolsuppressesanaphylacticreactions.Inbronchialepithelialcells,procaterolinhibitsreleaseofRANTES,GM-CSF,andIL-8,inhibitingeosinophilchemotaxis.Additionally,procateroldecreasesexpressionofintracellularadhesionmolecule1(ICAM-1)andvascularcellularadhesionmolecule1(VCAM-1),inhibitingadhesionofeosinophilstofibroblasts.
References
BaoW,ChenQ,LinY,etal.Efficacyofprocaterolcombinedwithinhaledbudesonidefortreatmentofcough-variantasthma.Respirology.2013Nov;18Suppl3:53-61.PMID:24188204.
YoshidaN,MuraguchiM,KamataM,etal.Procaterolpotentiatestheanti-inflammatoryactivityofbudesonideoneosinophiladhesiontolungfibroblasts.IntArchAllergyImmunol.2009;150(4):352-8.PMID:19571567.
KoyamaS,SatoE,MasubuchiT,etal.ProcaterolinhibitsIL-1beta-andTNF-alpha-mediatedepithelialcelleosinophilchemotacticactivity.EurRespirJ.1999Oct;14(4):767-75.PMID:10573218.
OhuchiK,HirasawaN,TakedaH,etal.Mechanismofantianaphylacticactionofbeta-agonistsinallergicinflammationofairpouchtypeinrats.IntArchAllergyApplImmunol.1987;82(1):26-32.PMID:2879797.